Rare Neurological Disease Special Report

HNF Featured in Rare Neurological Disease Special Report

by | Apr 9, 2019 | 0 comments

rare neurological disease special report

The Hereditary Neuropathy Foundation is proud to announce that for the fifth year in a row, we have been featured in the annual Rare Neurological Disease Special Report—a widely-read supplement included in the mailing of the March issues of Neurology Reviews. It is also distributed at all major neurology conferences throughout the year, including the 2019 MDA Clinical and Scientific Conference in Orlando, Florida April 13th-17th. If you attend come visit HNF at the Neurology Reviews booth.

We are diligently educating neurologists and Health Care Providers about CMT on your behalf.

Neurology Reviews is the first and original news source in neurology and has a history of providing independent, unbiased news to neurologists and clinicians interested in the neurosciences.

Here is what HNF featured in the March, 2019 edition: 

  • HNF ad “What is CMT?” page 10

  • “FDA Hears the CMT Community Voice Loud and Clear on September 28, 2018” page 11

  • “CMT1A and Impaired Patient Mobility: Expressions, Remedies, and Impact of Quality of Life” page 12

  • HNF’s Industry Partners Pharnext & Acceleron page 35 & 36

  • HNF’s Research Partner Dr. Stephen Züchner page 38-41

  • PSA Genetic Testing Awareness for Neurologists page 80

As with all of HNF’s programs, we rely on donations and support from our industry sponsors, government grants and YOU! Please donate today to support our continued medical outreach initiatives.

Learn more on this topic

Related Blog Posts

New Study on CMT Type 2B

If we are to learn more about CMT and the effectiveness of rehabilitation it is worth asking the patient and their caregiver. A recent Italian study by Padua et al recently described a survey of CMT patients and caregivers and their perspectives and perceptions of rehabilitation efficacy and needs.

Allison Moore is going to be published!

HNF’s CSO (Chief Scientific Officer), Sean Ekins wrote a blog about his work with Allison Moore and her two “fighter Mom” friends Lori Sames and Jill Wood. He named his blog: “Rare disease heroes – Extraordinary collaborators we should be listening too.” Sean helped my friends and I write a paper called: “Multifaceted roles of ultra rare and rare disease patients/parents in drug discovery.” YES, Allison Moore is going to be published! It will be in Drug Discovery Today, soon. The link to the reprint is below.

HNF-WVU-NIOSH Study update:

We are pleased to update our readers on the progress of the WVU-NIOSH study, “A Bi-Directional Translational Model of Exercise Training in the Treatment of Charcot-Marie-Tooth Disease”

Dr. Robert Baloh Answers Our Questions About iPS Cell Research

Big news is happening on a cellular level at Cedars-Sinai Medical Center’s Regenerative Medicine Institute in Los Angeles, CA.  Robert H. Baloh, MD PhD, Director of Neuromuscular Medicine, in conjunction with Patrick D. Lyden, MD Neurology Dept. Chair, and Clive Svendsen, PhD, Institute Director, are studying disorders that start in nerve cells. 

Join the conversation

Leave a Comment


Submit a Comment

Your email address will not be published. Required fields are marked *


Join for notifications on events, campaigns, & news